Our news

• Pharmaceutical Forum 2020. New is the understudied old

  04 December 2020

  

  Rustam Iksanov, Vice President for R&D at NovaMedica, believes one of the most important trends in development of the modern pharmaceutical market to be supergenerics. He spoke about this in his address at the Russian Pharmaceutical Forum in Moscow.

• Pharmaceutical Forum 2020. Key points first hand

  01 December 2020

  

  24-25 ноября Институт Адама Смита провел важнейшее для российской фарминдустрии мероприятие – Российский фармацевтический форум. Одну из наиболее важных панелей Форума – «ФАРМАЦЕВТИКА БУДУЩЕГО В РОССИИ И В МИРЕ: ГЛОБАЛЬНЫЙ ВЗГЛЯД НА ТРАНСФОРМАЦИЮ ОТРАСЛИ» - модерировала гендиректор НоваМедики Елена ЛИТВИНОВА. Она поделилась своими впечатлениями о ходе дискуссии и о проблемах отрасли, которые вскрыл ФармФорум.

• Four top managers of NovaMedica make it to the TOP 1000 Russian Managers 2020

  15 September 2020

  

  Four top managers of the pharmaceutical company NovaMedica were named among the business leaders in the annual Top 1000 Russian Managers rating published by the Russian Managers Association and the Kommersant Publishing House.

• NovaMedica will continue working remotely

  20 March 2020

  

  ​Health and safety of patients, our employees and their families take the highest priority for NovaMedica. As the COVID-19 situation is developing rapidly, we follow the recommendations of the federal and local authorities to prevent the infection from spreading. On March 19, NovaMedica started operating remotely.

• Marina Egorova to take charge of commerce and marketing at NovaMedica

  20 November 2019

  

  Russian pharmaceutical company NovaMedica announces the appointment of Marina Egorova, formerly director of business development, as head of the company’s commercial unit. Yulia Sobakina, who was in charge of commerce and marketing at NovaMedica since November 2017, will move on to assume the position of commercial director at Magnit Pharma LLC.  

• Elena Litvinova appointed new CEO of NovaMedica

  25 October 2019

  

  Russian pharmaceutical company NovaMedica announces the appointment of the Vice President for Business Development Elena Litvinova to the position of its CEO. Alexander Kuzin, who was the head of NovaMedica since June 2015, has moved on to work for Pharmacy Chain 36.6 where he will take charge of the retail segment.

• NovaMedica and UNIPHARM to localize the production of Melaxen in Russia at the capacities of the R&D Center NovaMedica Innotech

  25 July 2019

  

  Russian pharmaceutical company NovaMedica and US-based Unipharm have launched a joint project to localize in Russia the production of Melaxen®, a drug that improves the sleep/wake cycle. Volumes are expected to reach hundreds of thousands of units per year, which will be sufficient to fully meet the needs of patients living in the territory of the EAEU.

• NovaMedica and Pharmsynthez agreed to establish full-cycle manufacturing of several in-demand products in Russia

  17 June 2019

  

  Russian pharmaceutical companies NovaMedica and Pharmsynthez started implementing a joint project to ensure access to a number of effective products, with the full manufacturing cycle localized in Russia, for Russian patients within 1.5-2 years. The products are in the anesthesiology and gastroenterology therapeutic areas, intended for both the hospital and commercial markets.

• PharmNews: NovaMedica Innotech debuts on CPhI

  09 October 2018

  

  The international exhibition CPhI has started in Madrid. And today NovaMedica Innotech is in our focus as the company that has made a bright debut at the exhibition. This Technological Center has launched in April 2017 and Moscow Mayor Sergei Sobyanin attended the opening ceremony.

• Five senior managers of NovaMedica were named among the nominees of the Top-1000 Russian Managers rating list for 2018

  25 September 2018

  

  In 2018 Alexander Kuzin, General Director of NovaMedica, was ranked among the most recognized senior managers in the pharmaceutical industry for the fifth time in the rating list. Maria Makarova, Deputy General Director and Vice-President for Finance; Marina Aivazova, Vice-President for Personnel Management and Administrative Matters; Yulia Sobakina, Vice-President for Commerce and Marketing; Tatiana Albaut, PR Director were also included into this competent rating.